Australian researchers have developed a smartphone app that could not only help people recovering from alcohol use disorder to avoid relapsing but also support those who engage in harmful drinking to ...

For decades, researchers and clinicians have focused on a mother’s contribution to child obesity, with study findings consistently highlighting significant drivers such as preconception ...

Ponesimod is well tolerated and effective for up to 13 years in patients with relapsing-remitting multiple sclerosis, a combined analysis shows.

Up to 85% of patients with biomarker-confirmed atypical Alzheimer’s disease (AD) may be ineligible for anti-amyloid therapy under current trial and appropriate-use criteria, despite most having ...

The anatomical pattern of inflammatory back pain at disease onset may reveal which patients face a heightened risk for joint ...

Patients with early Raynaud's phenomenon who show both abnormal nailfold capillaries and positive antinuclear antibodies face ...

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third ...

A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.

Dupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.

Low-dose fentanyl and morphine offer no relief from persistent breathlessness in severe chronic obstructive pulmonary disease (COPD), a study finds.

A new study looks at the effect of home delivery of healthy groceries on A1c levels and food and nutrition security in vulnerable patients with type 2 diabetes.

Too often, clinicians add medications, appointments, and treatments without considering the cumulative burden has become unmanageable.